Clinical Trials Logo
  1. Home
  2. Behcet's Disease
  3. NCT06276829
  4. Details
NCT06276829 Clinical Trial

Behçet and LDH/Albumin

Behcet's Disease Clinical Trial

Official title:
A Convenient Parameter for Predicting Behçet's Disease Severity: Lactate Dehydrogenase/Albumin Ratio

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT06276829
Other study ID # 02.05.2023/291
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 1, 2020
Est. completion date April 1, 2023

Study information
Verified date February 2024
Source Ataturk University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

ABSTRACT Objective: To investigate whether the lactate dehydrogenase to albumin ratio can be used as a parameter to determine disease severity in Behçet's disease, an inflammatory disease, by comparing it to healthy controls. Patients and Methods: In this retrospective cohort study, patients with Behçet's disease aged 18-69 years who presented to the outpatient clinic between February 2020 and April 2023 and healthy individuals of similar age and gender were enrolled. LDH, albumin levels, and LDH/albumin ratio of both groups were compared. Clinical findings and characteristics of Behçet's patients and disease severity were recorded and analyzed in relation to LDH/albumin ratio.

Recruitment information / eligibility
Status Completed
Enrollment 1
Est. completion date April 1, 2023
Est. primary completion date April 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 69 Years
Eligibility Inclusion Criteria: Patients with Behçet's disease aged 18-69 Exclusion Criteria: - younger than 18 years or older than 69 years, pregnant and lactating patients, patients with acute infection on admission or nutritional problems, symptomatic gastrointestinal symptoms, malignancy, hepatitis or liver disease were excluded.

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• LDH/albumin ratio
LDH/Albumin ratios of patient and control groups were recorded.

Locations
Country Name City State
Turkey Erdal Pala Erzurum

Sponsors (1)
Lead Sponsor Collaborator
Ataturk University

Country where clinical trial is conducted

Turkey, 

Outcome
Type Measure Description Time frame Safety issue
Primary LDH/albumin ratio February 2020 and April 2023
See also
  Status Clinical Trial Phase
Recruiting NCT05635266 - Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Completed NCT02190916 - Vasculitis Illness Perception (VIP) Study N/A
Completed NCT04065672 - Low-dose IL-2 Treatment on Behcet's Disease Phase 2
Recruiting NCT02593565 - Vasculitis Pregnancy Registry
Completed NCT00167583 - Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB) Phase 3
Completed NCT03371095 - Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease Phase 3
Completed NCT01960790 - Special Investigation in Patients With Intestinal Behcet's Disease (All Case Investigation)
Completed NCT03531385 - Assessment of Central Sensitization, Neuropathic Pain, Sleep Quality and Daily Life Activities in Behcet's Disease
Completed NCT02190942 - VCRC Patient Contact Registry Patient-Reported Data Validation Study
Completed NCT04328064 - The Role of Rosuvastatin on Vascular Involvement in Behçet's Disease N/A
Not yet recruiting NCT06285539 - Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases Phase 2
Completed NCT02190929 - Educational Needs of Patients With Systemic Vasculitis N/A
Completed NCT02476292 - Impact of Vasculitis on Employment and Income N/A
Completed NCT03543709 - Evaluation of Fibromyalgia With Disease Activity and Clinical Findings in Women With Behçet's Disease
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Completed NCT01988506 - Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Phase 2
Recruiting NCT01952275 - Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases N/A
Completed NCT01532570 - Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions Phase 3
Completed NCT03410290 - Journey of Patients With Vasculitis From First Symptom to Diagnosis
Completed NCT02176070 - Reproductive Health in Men and Women With Vasculitis N/A